Nanostructured Microelectrodes for Ultrasensitive Biomarker Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current multiplexed biosensing devices face challenges in achieving direct electronic detection of biomarkers in cellular and clinical samples due to high background noise levels and difficulty in obtaining low detection limits, especially when using complex biological samples, which limits their implementation in routine patient care.
Innovation Solution
The development of nanostructured microelectrodes (NMEs) with increased surface area, made from conductive materials such as noble metals, conducting polymers, and metal oxides, which are arrayed on substrates and functionalized with probes for sensitive biomolecular detection, enabling ultrasensitive and specific detection of nucleic acids and proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional macroelectrodes are used for biomarker detection, then the device structure is simple and easy to manufacture, but the detection sensitivity is insufficient and background noise levels are high
Solution Approach 1:
The patent transitions from macroelectrodes to microelectrodes with dimensions in the micrometer to nanometer range. This dimensional reduction increases the surface area to volume ratio, enhancing detection sensitivity while enabling integration into compact chip-based devices for multiplexed biomarker detection.
Solution Approach 2:
The patent employs nanotextured electrodes with porous or fractal surface structures. These nanostructured surfaces provide dramatically increased effective surface area for biomarker binding, improving detection sensitivity and signal-to-noise ratio while maintaining a compact overall device structure.
2Measurement precision
If micro- to nano-scale electrodes are used to enhance sensitivity, then detection limits are improved, but fabrication becomes labour-intensive and insufficiently reproducible
Solution Approach 1:
The patent systematically varies electrode dimensions, surface textures, and material compositions to optimize detection performance. By controlling parameters such as electrode size (1-100 micrometers), surface area to volume ratio, and nanotexture characteristics, the patent achieves enhanced sensitivity while establishing reproducible fabrication protocols.
Solution Approach 2:
The patent utilizes composite electrode structures combining different materials (e.g., metals, metal oxides, conducting polymers) with specific nanoscale architectures. These composite structures provide both enhanced electrochemical properties for sensitive detection and improved manufacturability through established deposition and fabrication techniques.
3Measurement precision
If nanostructured microelectrodes are implemented, then ultrasensitive detection is achieved, but the device complexity and fabrication difficulty increase
Solution Approach 1:
The patent divides the electrode surface into multiple discrete nanostructured elements or pixels arranged in arrays. Each microelectrode element can be independently fabricated and characterized, simplifying quality control and enabling parallel production while achieving high overall sensitivity through the collective response of multiple elements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
NMEs provide a robust and versatile platform for ultrasensitive detection of biomarkers, achieving low detection limits and high specificity, facilitating multiplexed analysis of biomarkers in clinical samples with improved reproducibility and cost-effectiveness compared to traditional methods.
Implementation Method 1
The microelectrode is adapted to generate a charge in response to a biomolecular stimulus
Data Source
AI summary
Nanostructured microelectrodes and biosensing devices incorporating the same are disclosed herein.


